HemaSphere Issues Research Articles in October 2024 Edition
October 22, 2024
October 22, 2024
THE HAGUE, The Netherlands, Oct. 22 -- HemaSphere, a peer-reviewed journal from the European Hematology Association that says it features hematology, published research articles on the following topics in its October 2024 edition (Vol. 8, Issue 10):
ARTICLE
* Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study
HemaTopics
* Ov . . .
ARTICLE
* Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study
HemaTopics
* Ov . . .